Immunocore Hldgs第四季度每股收益$(0.47) 低于预期$(0.24),销售额$84.05M 超过预期$83.55M

财报速递02-26
Immunocore Hldgs (NASDAQ:IMCR)报告季度每股亏损$(0.47),低于分析师一致预期的$(0.24),差距为95.83%。与去年同期每股亏损$(0.40)相比,这一数据减少了17.5%。公司报告季度销售额为$84.05M,高于分析师一致预期的$83.55M,增幅为0.60%。与去年同期销售额$70.16M相比,这一数据增长了19.80%。

以上内容来自Benzinga Earnings专栏,原文如下:

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.24) by 95.83 percent. This is a 17.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $84.05 million which beat the analyst consensus estimate of $83.55 million by 0.60 percent. This is a 19.80 percent increase over sales of $70.16 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法